A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cause life-threatening diseases in millions of people worldwide and there is an urgent need for antiviral agents against this infection. While in vitro activities of artemisinins (containing endoperoxide moiety) and chloroquine (containing quinoline subunit) against SARS-CoV-2 have recently been demonstrated, no study of artemisinin-and quinoline-based hybrids has been reported yet. However, the hybrid drug'sdoi:10.33774/chemrxiv-2021-qlk08 fatcat:th2ee43xbjhmtden6jcbiwmofa